| Literature DB >> 34684725 |
Vittorio Bolcato1, Claudia Carelli1, Alessandra Radogna1, Francesca Freni1, Matteo Moretti1, Luca Morini1.
Abstract
The analysis of psychoactive substances in hair is of great importance for both clinical and forensic toxicologists since it allows one to evaluate past and continuative exposure to xenobiotics. In particular, a new challenge is represented by new psychoactive substances: Among this new class of drugs of abuse, synthetic cathinone and phenethylamine derivatives are often detected in biological samples. Hence, there is a growing need to develop new analytical procedures or improve old ones in order to conduct evaluations of these emerging substances. This study is a systematic review of all the instrumental and experimental data available in the literature. A total of 32 articles were included in the review. Acidic solvents proved to be the most reliable solutions for extraction. Gas chromatography and liquid chromatography coupled to tandem mass spectrometric and high-resolution mass spectrometric systems represent the majority of the involved instrumental techniques. Sensitivity must be maintained at the pg/mg level to detect any occurrences up to occasional consumption. In total, 23 out of 32 articles reported real positive samples. The most frequently detected substance in hair was mephedrone, followed by butylone, methylone, MDPV, and α-pyrrolidinophenone-type substances.Entities:
Keywords: NPS; hair analysis; phenylethylamine and derivatives; synthetic cathinones
Mesh:
Substances:
Year: 2021 PMID: 34684725 PMCID: PMC8538434 DOI: 10.3390/molecules26206143
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Most-frequently detected new synthetic cathinones in hair.
| Substance | Number of Cases (n. of Articles) | Concentration Range in ng/mg |
|---|---|---|
| mephedrone | 83 (12) | 0.005–313.2 |
| butylone | 42 (4) | 0.001–4.9 |
| 4-MEC | 31 (7) | 0.001–97.3 |
| MDMC | 26 (6) | 0.006–21.7 |
| MDPV | 19 (9) | 0.001–11.66 (−300–350 *) |
| α-PVP | 19 (11) | 0.001–1.04 (−300–350 *) |
| 4-FA | 16 (5) | 0.029–7.8 |
| MXE | 15 (6) | 0.03–2.93 |
| EPH | 4 (3) | 0.11–1.17 |
| cathinone | 3 (3) | 0.1–1.27 |
| TFMPP | 3 (3) | 0.003–0.03 |
| α-PHP | 3 (3) | 0.019–4.7 |
Legend: 4-MEC: 4-Methylethcathinone; MDMC: Methylone; MDPV: 3,4-Methylenedioxypyrovalerone; α-PVP: α-pyrrolidinopentiophenone; 4-FA: 4-Fluoroamphetamine; MXE: Methoxetamine; EPH: Ethylphenidate; TFMPP: Trifluoromethylphenylpiperazine; α-PHP: α-pyrrolidinohexiophenone. mCPP: Meta-chlorophenylpiperazine; DXM: Dextromethorphane; 2-CE: 2,5-dimethoxy-4. * Concentration not clearly reported in the article. See Table S1 from Supplementary Materials for details.
Figure 1PRISMA flowchart showing the study selection process.